{"id":23493,"date":"2023-11-07T12:37:50","date_gmt":"2023-11-07T20:37:50","guid":{"rendered":"https:\/\/ameripharmaspecialty.com\/?p=23493"},"modified":"2025-02-11T16:01:52","modified_gmt":"2025-02-11T23:01:52","slug":"kisqali-a-first-line-treatment-option-for-breast-cancer","status":"publish","type":"post","link":"https:\/\/ameripharmaspecialty.com\/es\/cancer\/kisqali-a-first-line-treatment-option-for-breast-cancer\/","title":{"rendered":"Kisqali: Una opci\u00f3n de tratamiento de primera l\u00ednea para el c\u00e1ncer de mama"},"content":{"rendered":"\n<p><span style=\"font-weight: 400;\">Kisqali is an oral medication used to treat certain types of advanced or metastatic breast cancer. It is considered a first-line treatment option. It is also effective in extending survival when combined with hormone therapy.<\/span><\/p>\n\n\n\n<div  id=\"call-to-action-d4c21770df5e14cf84909c4305e2c8a1\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tGet Chemotherapy Copay Assistance\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"cta__sub__heading\">\n\t\t\t\t\t\t\tChemotherapy\u00a0Financial Assistance\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"tel:8777780318\">(877) 778-0318<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<p><span style=\"font-weight: 400;\"><a href=\"https:\/\/www.novartis.com\/\">Novartis<\/a>, a Swiss multinational pharmaceutical company, developed Kisqali. It works by blocking specific enzymes that promote cancer cell division.&nbsp;<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">The drug was discovered in the late 2000s as part of a research program to find inhibitors of cyclin-dependent kinases (CDKs). CDKs are enzymes involved in cell cycle regulation. Novartis recognized Kisqali&#8217;s potential as a cancer therapy and began clinical trials in breast cancer patients in 2013. In March 2017, the <a href=\"https:\/\/www.fda.gov\/\">FDA<\/a> approved the drug for the treatment of hormone receptor (HR)-positive, HER2-negative advanced or metastatic breast cancer in postmenopausal women. Later that year, the drug was approved for the same indication in Europe. The FDA expanded its approval to include premenopausal and perimenopausal women in July 2018.<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">Since its approval, Kisqali has become a great treatment option for advanced and metastatic breast cancer patients.&nbsp;<\/span><\/p>\n\n\n\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_82_2 counter-hierarchy ez-toc-counter ez-toc-custom ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/kisqali-a-first-line-treatment-option-for-breast-cancer\/#What_Is_Kisqali_Used_To_Treat\" >What Is Kisqali Used To Treat?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/kisqali-a-first-line-treatment-option-for-breast-cancer\/#How_Kisqali_Works\" >How Kisqali Works<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/kisqali-a-first-line-treatment-option-for-breast-cancer\/#Side_Effects\" >Side Effects<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/kisqali-a-first-line-treatment-option-for-breast-cancer\/#Mild_Side_Effects\" >Mild Side Effects<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/kisqali-a-first-line-treatment-option-for-breast-cancer\/#Serious_Side_Effects\" >Serious Side Effects<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/kisqali-a-first-line-treatment-option-for-breast-cancer\/#Dosage_and_Treatment\" >Dosage and Treatment<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/kisqali-a-first-line-treatment-option-for-breast-cancer\/#Before_Taking_Kisqali\" >Before Taking Kisqali<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/kisqali-a-first-line-treatment-option-for-breast-cancer\/#Kisqali_Cost\" >Kisqali Cost<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/kisqali-a-first-line-treatment-option-for-breast-cancer\/#FAQs\" >FAQs<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\" id=\"h-what-is-kisqali-used-to-treat\"><span class=\"ez-toc-section\" id=\"What_Is_Kisqali_Used_To_Treat\"><\/span>What Is Kisqali Used To Treat?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">Kisqali is a brand-name prescription drug used to treat an advanced type of breast cancer in women. It is used to treat breast cancer that has all the following properties [1]:<\/span><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><b>Metastatic or locally advanced:<\/b><span style=\"font-weight: 400;\"> Kisqali can treat breast cancer that is advanced (metastatic) or locally advanced. Metastatic means that the cancer has spread to different body parts, including the bones, liver, brain, and lungs. Locally advanced means that the cancer has spread to the breast area and structures, such as nearby lymph nodes, muscle, and skin, but not to other body parts.<\/span><\/li>\n\n\n\n<li><b>Hormone receptor-positive (HR-positive): <\/b><span style=\"font-weight: 400;\">Kisqali can help with hormone receptor positive (HR+) breast cancer.&nbsp;<\/span><\/li>\n\n\n\n<li><b>HER2-negative (HER2-): <\/b><span style=\"font-weight: 400;\">Kisqali can help with a type of breast cancer that does not have the human epidermal growth factor receptor (HER2-).<\/span><\/li>\n<\/ul>\n\n\n\n<p><b>Note:<\/b><span style=\"font-weight: 400;\"> Kisqali&#8217;s safety and effectiveness in children are unknown.&nbsp;<\/span><\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-how-kisqali-works\"><span class=\"ez-toc-section\" id=\"How_Kisqali_Works\"><\/span>How Kisqali Works<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">Kisqali is used to treat specific types of breast cancer. The active component in Kisqali is ribociclib. It works by inhibiting enzymes called CDK4 and CDK6. These enzymes regulate cell development in both cancerous and normal cells. These enzymes can become hyperactive in cancer cells, leading them to divide and grow uncontrollably. By blocking these enzymes, Kisqali can reduce or stop the growth of cancer cells in the body.<\/span><\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-side-effects\"><span class=\"ez-toc-section\" id=\"Side_Effects\"><\/span>Side Effects<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">Like all medications, Kisqali can also cause side effects. In rare cases, it can also cause some severe side effects. The FDA has warned that Kisqali could cause fatal lung problems [7].&nbsp;<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">Here are some mild to severe side effects [1]:<\/span><\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-mild-side-effects\"><span class=\"ez-toc-section\" id=\"Mild_Side_Effects\"><\/span>Mild Side Effects<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"alignright\"><img loading=\"lazy\" decoding=\"async\" width=\"420\" height=\"268\" src=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/back-pain.jpg\" alt=\"Woman with back pain as a side effect of taking Kisqali\" class=\"wp-image-23496\" srcset=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/back-pain.jpg 420w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/back-pain-300x191.jpg 300w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/back-pain-86x55.jpg 86w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/back-pain-167x107.jpg 167w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/back-pain-280x179.jpg 280w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/back-pain-370x236.jpg 370w\" sizes=\"auto, (max-width: 420px) 100vw, 420px\" \/><\/figure>\n<\/div>\n\n\n<p><span style=\"font-weight: 400;\">The following are some of the most common mild side effects of using Kisqali:<\/span><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><span style=\"font-weight: 400;\">Nausea<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Back pain<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Fatigue<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Vomiting<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Diarrhea<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Constipation<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Hair loss<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Low white blood cell counts<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Headache<\/span><\/li>\n<\/ul>\n\n\n\n<p><span style=\"font-weight: 400;\">Most of these side effects may disappear within a few days or weeks. Consult your doctor or pharmacist if they become more severe or do not go away.<\/span><\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-serious-side-effects\"><span class=\"ez-toc-section\" id=\"Serious_Side_Effects\"><\/span>Serious Side Effects<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p><span style=\"font-weight: 400;\">As stated earlier, serious side effects are rare but can occur. If you experience any of the listed serious side effects, contact your doctor immediately.&nbsp;<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">Serious side effects can include:<\/span><\/p>\n\n\n\n<p><b>Heart problems:<\/b><span style=\"font-weight: 400;\"> Kisqali can cause abnormal heartbeat, leading to death. Symptoms can include dizziness, fast heartbeat, faintness, and irregular heartbeat.<\/span><\/p>\n\n\n\n<p><b>Liver problems:<\/b><span style=\"font-weight: 400;\"> Severe liver problems can occur during treatment. Performing liver function tests before and during treatment is important. Symptoms of liver problems include loss of appetite, yellowing of your skin or the whites of your eyes, stomach pain, and dark urine.<\/span><\/p>\n\n\n\n<p><b>Lung problems:<\/b><span style=\"font-weight: 400;\"> You may encounter severe lung problems during Kisqali treatment, leading to death. Signs of the problem may be difficulty breathing, pain in the chest, and coughing.<\/span><\/p>\n\n\n\n<p><b>Low white blood cell counts: <\/b><span style=\"font-weight: 400;\">While using Kisqali, low white blood cell counts are common and can lead to dangerous infections.<\/span><\/p>\n\n\n\n<p><b>Severe skin problems:<\/b><span style=\"font-weight: 400;\"> You may experience a severe rash that progressively worsens. Symptoms can include red or flushed skin, peeling skin, blisters, fever, and body aches.<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">Please note that the list of side effects provided is not comprehensive. Seek immediate medical attention if you experience any severe side effects.<\/span><\/p>\n\n\n\n<div  id=\"call-to-action-85bcee098fb2173f8cc481ed1d37578b\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tConsult a Chemotherapy Specialist\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"cta__sub__heading\">\n\t\t\t\t\t\t\tGet Chemotherapy Treatment Assistance\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"#form\">Schedule a Consultation<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-dosage-and-treatment\"><span class=\"ez-toc-section\" id=\"Dosage_and_Treatment\"><\/span>Dosage and Treatment<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">Kisqali is available in a 200 mg tablet form. The duration of one treatment cycle is 4 weeks. During the first 3 weeks of the cycle, three tablets totaling 600 mg are administered once daily with or without food. After the 3-week period, there is a 1-week break before the next cycle begins.<\/span><\/p>\n\n\n\n<p><b>Note:<\/b><span style=\"font-weight: 400;\"> If severe side effects occur, your doctor can lower your dose or stop the treatment.<\/span><\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-before-taking-kisqali\"><span class=\"ez-toc-section\" id=\"Before_Taking_Kisqali\"><\/span>Before Taking Kisqali<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">Kisqali should not be used if you are allergic to ribociclib or if you are also taking <a href=\"https:\/\/www.breastcancer.org\/treatment\/hormonal-therapy\/tamoxifen\">tamoxifen<\/a>. Your doctor will order blood tests to check that you do not have any issues that might prevent you from safely taking Kisqali.<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">To ensure that the medication is safe for you, inform your doctor if you <\/span>have ever had:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><span style=\"font-weight: 400;\">Slow heartbeats<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">A history of heart disease or a previous heart attack<\/span><\/li>\n\n\n\n<li><a href=\"https:\/\/www.hopkinsmedicine.org\/health\/conditions-and-diseases\/long-qt-syndrome-lqts#:~:text=Long%20QT%20syndrome%20(LQTS)%20is,fainting)%20or%20sudden%20cardiac%20death.\"><span style=\"font-weight: 400;\">Long QT syndrome<\/span><\/a><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Liver disease<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Kidney disease<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Signs of infection (fever, chills)<\/span><\/li>\n<\/ul>\n\n\n\n<p><span style=\"font-weight: 400;\">Also, let your doctor know if you&#8217;ve gone through menopause. You may need to have a negative pregnancy test before starting this treatment.<\/span><\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-kisqali-cost\"><span class=\"ez-toc-section\" id=\"Kisqali_Cost\"><\/span>Kisqali Cost<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">According to the official website, Kisqali tablets can cost around $6,000 to $15,000 per month, depending on your dose [5]. But the treatment&#8217;s actual cost depends on your insurance plan, location, and the pharmacy you visit. <a href=\"https:\/\/ameripharmaspecialty.com\/financial-assistance\/\">Contact us<\/a> if you are interested in copay or financial assistance.&nbsp;<\/span><\/p>\n\n\n\n<div  id=\"call-to-action-93b3f493ea3cfd0569ad91073d0ce290\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tSpeak to a Specialist\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"cta__sub__heading\">\n\t\t\t\t\t\t\tAbout Copay Assistance\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"tel:8777780318\">(877) 778-0318<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-faqs\"><span class=\"ez-toc-section\" id=\"FAQs\"><\/span>FAQs<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">Here are answers to frequently asked questions about Kisqali:<\/span><\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-is-kisqali-a-kind-of-chemotherapy\">Is Kisqali a kind of chemotherapy?<\/h4>\n\n\n\n<p><span style=\"font-weight: 400;\">Yes. It is an oral <a href=\"https:\/\/ameripharmaspecialty.com\/conditions-treatments\/cancer\/\">chemotherapy<\/a> drug that signals cancer cells to stop growing.<\/span><\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-is-kisqali-safe-to-use-during-pregnancy\">Is Kisqali safe to use during pregnancy?<\/h4>\n\n\n\n<p><span style=\"font-weight: 400;\">Kisqali is not recommended during pregnancy because it could harm your unborn child. If you are a female of reproductive age taking Kisqali, you should take birth control during treatment and for 3 weeks after the last dosage. If you become pregnant while using this medicine, inform your healthcare provider immediately.<\/span><\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-is-it-safe-to-take-kisqali-while-breastfeeding\">Is it safe to take Kisqali while breastfeeding?<\/h4>\n\n\n\n<p><span style=\"font-weight: 400;\">Breastfeeding is not recommended while using Kisqali. We don&#8217;t know if the medicine can pass into your breast milk. But if it does, breastfeeding infants are in danger of serious harm. You should not breastfeed while taking this medication and for 3 weeks after your final dosage because of this risk. Talk with your provider about other options for feeding your baby during therapy.&nbsp;<\/span><\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-what-are-the-clinical-benefits-of-kisqali\">What are the clinical benefits of Kisqali?<\/h4>\n\n\n\n<p><span style=\"font-weight: 400;\">Kisqali is a drug that is used to treat hormone receptor-positive (HR+), human epidermal growth factor receptor-2 negative (HER2-) advanced breast cancer in women. It has some benefits over traditional treatments. Here are some clinical benefits of Kisqali:<\/span><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><span style=\"font-weight: 400;\">It can improve overall survival when used as a first-line treatment. According to a study, women treated with Kisqali and endocrine therapy lived about 1 year longer than women treated with endocrine therapy alone [8].<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">It can also improve progression-free survival. According to a study, women treated with Kisqali and <a href=\"https:\/\/www.webmd.com\/drugs\/2\/drug-4297\/letrozole-oral\/details\">letrozole<\/a> had 9 months of more progression-free survival than women treated with letrozole alone [8].<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Kisqali can improve the quality of life for patients [9].<\/span><\/li>\n<\/ul>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-can-kisqali-cause-me-to-lose-my-hair\">Can Kisqali cause me to lose my hair?<\/h4>\n\n\n\n<p>Possibly.<span style=\"font-weight: 400;\"> Hair loss is a very common side effect. Hair loss was reported in up to 33% of patients taking Kisqali in conjunction with other hormone treatments in studies [6]. If you are concerned about hair loss, talk with your provider.<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>El Kisqali es un medicamento oral que se utiliza para tratar ciertos tipos de c\u00e1ncer de mama avanzado o metast\u00e1sico. Se considera el tratamiento de primera l\u00ednea. Tambi\u00e9n es eficaz para prolongar la supervivencia cuando se combina con terapia hormonal.<\/p>","protected":false},"author":7,"featured_media":23495,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"om_disable_all_campaigns":false,"_uag_custom_page_level_css":"","footnotes":""},"categories":[13],"tags":[8],"class_list":["post-23493","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-cancer","tag-dr-christine-leduc"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Kisqali: A First-Line Treatment Option for Breast Cancer<\/title>\n<meta name=\"description\" content=\"Learn about Kisqali and how it is used to treat metastatic breast cancer. Topics include how the drug works, side effects, dosage, and more.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/kisqali-a-first-line-treatment-option-for-breast-cancer\/\" \/>\n<meta property=\"og:locale\" content=\"es_MX\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Kisqali: A First-Line Treatment Option for Breast Cancer\" \/>\n<meta property=\"og:description\" content=\"Learn about Kisqali and how it is used to treat metastatic breast cancer. Topics include how the drug works, side effects, dosage, and more.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/kisqali-a-first-line-treatment-option-for-breast-cancer\/\" \/>\n<meta property=\"og:site_name\" content=\"AmeriPharma\u00ae Specialty Care\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ameripharma\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-11-07T20:37:50+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-02-11T23:01:52+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/breast-cancer-awareness.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"853\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Dr. Christine Leduc, PharmD\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Dr. Christine Leduc, PharmD\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/cancer\\\/kisqali-a-first-line-treatment-option-for-breast-cancer\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/cancer\\\/kisqali-a-first-line-treatment-option-for-breast-cancer\\\/\"},\"author\":{\"name\":\"Dr. Christine Leduc, PharmD\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#\\\/schema\\\/person\\\/0d161a7a3c2b0cf54ab0cf25c936dd87\"},\"headline\":\"Kisqali: A First-Line Treatment Option for Breast Cancer\",\"datePublished\":\"2023-11-07T20:37:50+00:00\",\"dateModified\":\"2025-02-11T23:01:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/cancer\\\/kisqali-a-first-line-treatment-option-for-breast-cancer\\\/\"},\"wordCount\":1243,\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/cancer\\\/kisqali-a-first-line-treatment-option-for-breast-cancer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2023\\\/11\\\/breast-cancer-awareness.jpg\",\"keywords\":[\"Dr. Christine Leduc\"],\"articleSection\":[\"Cancer\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/cancer\\\/kisqali-a-first-line-treatment-option-for-breast-cancer\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/cancer\\\/kisqali-a-first-line-treatment-option-for-breast-cancer\\\/\",\"name\":\"Kisqali: A First-Line Treatment Option for Breast Cancer\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/cancer\\\/kisqali-a-first-line-treatment-option-for-breast-cancer\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/cancer\\\/kisqali-a-first-line-treatment-option-for-breast-cancer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2023\\\/11\\\/breast-cancer-awareness.jpg\",\"datePublished\":\"2023-11-07T20:37:50+00:00\",\"dateModified\":\"2025-02-11T23:01:52+00:00\",\"description\":\"Learn about Kisqali and how it is used to treat metastatic breast cancer. Topics include how the drug works, side effects, dosage, and more.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/cancer\\\/kisqali-a-first-line-treatment-option-for-breast-cancer\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ameripharmaspecialty.com\\\/cancer\\\/kisqali-a-first-line-treatment-option-for-breast-cancer\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/cancer\\\/kisqali-a-first-line-treatment-option-for-breast-cancer\\\/#primaryimage\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2023\\\/11\\\/breast-cancer-awareness.jpg\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2023\\\/11\\\/breast-cancer-awareness.jpg\",\"width\":1280,\"height\":853,\"caption\":\"Group of women wearing breast cancer awareness ribbons\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/cancer\\\/kisqali-a-first-line-treatment-option-for-breast-cancer\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Kisqali: A First-Line Treatment Option for Breast Cancer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/\",\"name\":\"AmeriPharma\u00ae Specialty Care\",\"description\":\"Specialty Care by AmeriPharma\",\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#organization\",\"name\":\"Ameripharma Specialty Care\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"width\":400,\"height\":400,\"caption\":\"Ameripharma Specialty Care\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/ameripharma\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#\\\/schema\\\/person\\\/0d161a7a3c2b0cf54ab0cf25c936dd87\",\"name\":\"Dr. Christine Leduc, PharmD\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/9f2e7e868ac19420a5672d88350e7e0e3c6a750140410fd606eec96984812e89?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/9f2e7e868ac19420a5672d88350e7e0e3c6a750140410fd606eec96984812e89?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/9f2e7e868ac19420a5672d88350e7e0e3c6a750140410fd606eec96984812e89?s=96&d=mm&r=g\",\"caption\":\"Dr. Christine Leduc, PharmD\"},\"description\":\"Dr. Christine Leduc, PharmD, was born and raised in Irvine, CA. She attended college at Midwestern University, where she graduated cum laude. The most rewarding part of her job is suggesting lifestyle changes, educating patients on how their medication works, and precepting future pharmacists. Her areas of expertise are customer service and knowledge of specialty medication. Having worked in the service industry in the past, she has gained the customer service skills necessary to understand the needs of her patients. Dr. Leduc is currently precepting students from Marshall B. Ketchum University, University of Kansas, and Midwestern University. In her free time, she enjoys traveling, baking, and gardening. See Author Biography\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/author\\\/christine-leduc\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Kisqali: Una opci\u00f3n de tratamiento de primera l\u00ednea para el c\u00e1ncer de mama","description":"Aprenda sobre el Kisqali y c\u00f3mo se usa para tratar el c\u00e1ncer de mama metast\u00e1sico. Los temas incluyen c\u00f3mo funciona el medicamento, sus efectos secundarios, su dosis y m\u00e1s.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ameripharmaspecialty.com\/es\/cancer\/kisqali-a-first-line-treatment-option-for-breast-cancer\/","og_locale":"es_MX","og_type":"article","og_title":"Kisqali: A First-Line Treatment Option for Breast Cancer","og_description":"Learn about Kisqali and how it is used to treat metastatic breast cancer. Topics include how the drug works, side effects, dosage, and more.","og_url":"https:\/\/ameripharmaspecialty.com\/es\/cancer\/kisqali-a-first-line-treatment-option-for-breast-cancer\/","og_site_name":"AmeriPharma\u00ae Specialty Care","article_publisher":"https:\/\/www.facebook.com\/ameripharma\/","article_published_time":"2023-11-07T20:37:50+00:00","article_modified_time":"2025-02-11T23:01:52+00:00","og_image":[{"width":1280,"height":853,"url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/breast-cancer-awareness.jpg","type":"image\/jpeg"}],"author":"Dr. Christine Leduc, PharmD","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Dr. Christine Leduc, PharmD","Est. reading time":"6 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ameripharmaspecialty.com\/cancer\/kisqali-a-first-line-treatment-option-for-breast-cancer\/#article","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/cancer\/kisqali-a-first-line-treatment-option-for-breast-cancer\/"},"author":{"name":"Dr. Christine Leduc, PharmD","@id":"https:\/\/ameripharmaspecialty.com\/es\/#\/schema\/person\/0d161a7a3c2b0cf54ab0cf25c936dd87"},"headline":"Kisqali: A First-Line Treatment Option for Breast Cancer","datePublished":"2023-11-07T20:37:50+00:00","dateModified":"2025-02-11T23:01:52+00:00","mainEntityOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/cancer\/kisqali-a-first-line-treatment-option-for-breast-cancer\/"},"wordCount":1243,"publisher":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/#organization"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/cancer\/kisqali-a-first-line-treatment-option-for-breast-cancer\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/breast-cancer-awareness.jpg","keywords":["Dr. Christine Leduc"],"articleSection":["Cancer"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/ameripharmaspecialty.com\/cancer\/kisqali-a-first-line-treatment-option-for-breast-cancer\/","url":"https:\/\/ameripharmaspecialty.com\/cancer\/kisqali-a-first-line-treatment-option-for-breast-cancer\/","name":"Kisqali: Una opci\u00f3n de tratamiento de primera l\u00ednea para el c\u00e1ncer de mama","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/cancer\/kisqali-a-first-line-treatment-option-for-breast-cancer\/#primaryimage"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/cancer\/kisqali-a-first-line-treatment-option-for-breast-cancer\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/breast-cancer-awareness.jpg","datePublished":"2023-11-07T20:37:50+00:00","dateModified":"2025-02-11T23:01:52+00:00","description":"Aprenda sobre el Kisqali y c\u00f3mo se usa para tratar el c\u00e1ncer de mama metast\u00e1sico. Los temas incluyen c\u00f3mo funciona el medicamento, sus efectos secundarios, su dosis y m\u00e1s.","breadcrumb":{"@id":"https:\/\/ameripharmaspecialty.com\/cancer\/kisqali-a-first-line-treatment-option-for-breast-cancer\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ameripharmaspecialty.com\/cancer\/kisqali-a-first-line-treatment-option-for-breast-cancer\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/ameripharmaspecialty.com\/cancer\/kisqali-a-first-line-treatment-option-for-breast-cancer\/#primaryimage","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/breast-cancer-awareness.jpg","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/breast-cancer-awareness.jpg","width":1280,"height":853,"caption":"Group of women wearing breast cancer awareness ribbons"},{"@type":"BreadcrumbList","@id":"https:\/\/ameripharmaspecialty.com\/cancer\/kisqali-a-first-line-treatment-option-for-breast-cancer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ameripharmaspecialty.com\/zh\/"},{"@type":"ListItem","position":2,"name":"Kisqali: A First-Line Treatment Option for Breast Cancer"}]},{"@type":"WebSite","@id":"https:\/\/ameripharmaspecialty.com\/es\/#website","url":"https:\/\/ameripharmaspecialty.com\/es\/","name":"Cuidado especializado AmeriPharma\u00ae","description":"Atenci\u00f3n especializada por AmeriPharma","publisher":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ameripharmaspecialty.com\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/ameripharmaspecialty.com\/es\/#organization","name":"Atenci\u00f3n especializada de Ameripharma","url":"https:\/\/ameripharmaspecialty.com\/es\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/ameripharmaspecialty.com\/es\/#\/schema\/logo\/image\/","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","width":400,"height":400,"caption":"Ameripharma Specialty Care"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ameripharma\/"]},{"@type":"Person","@id":"https:\/\/ameripharmaspecialty.com\/es\/#\/schema\/person\/0d161a7a3c2b0cf54ab0cf25c936dd87","name":"Dra. Christine Leduc, PharmD","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/9f2e7e868ac19420a5672d88350e7e0e3c6a750140410fd606eec96984812e89?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/9f2e7e868ac19420a5672d88350e7e0e3c6a750140410fd606eec96984812e89?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9f2e7e868ac19420a5672d88350e7e0e3c6a750140410fd606eec96984812e89?s=96&d=mm&r=g","caption":"Dr. Christine Leduc, PharmD"},"description":"La Dra. Christine Leduc, doctora en farmacia, naci\u00f3 y creci\u00f3 en Irvine, California. Curs\u00f3 estudios universitarios en la Universidad Midwestern, donde se gradu\u00f3 con honores. Lo m\u00e1s gratificante de su trabajo es sugerir cambios en el estilo de vida, educar a los pacientes sobre el funcionamiento de sus medicamentos y ser tutora de futuros farmac\u00e9uticos. Sus \u00e1reas de especializaci\u00f3n son la atenci\u00f3n al cliente y el conocimiento de medicamentos especializados. Tras haber trabajado en el sector servicios, ha adquirido las habilidades de atenci\u00f3n al cliente necesarias para comprender las necesidades de sus pacientes. Actualmente, la Dra. Leduc imparte clases a estudiantes de la Universidad Marshall B. Ketchum, la Universidad de Kansas y la Universidad Midwestern. En su tiempo libre, disfruta de viajar, la reposter\u00eda y la jardiner\u00eda. Ver biograf\u00eda de la autora.","url":"https:\/\/ameripharmaspecialty.com\/es\/author\/christine-leduc\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/breast-cancer-awareness.jpg",1280,853,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/breast-cancer-awareness-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/breast-cancer-awareness-300x200.jpg",300,200,true],"medium_large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/breast-cancer-awareness-768x512.jpg",768,512,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/breast-cancer-awareness-1024x682.jpg",1024,682,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/breast-cancer-awareness.jpg",1280,853,false],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/breast-cancer-awareness.jpg",1280,853,false],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/breast-cancer-awareness.jpg",18,12,false],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/breast-cancer-awareness.jpg",600,400,false],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/breast-cancer-awareness-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/breast-cancer-awareness-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/breast-cancer-awareness-86x57.jpg",86,57,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/breast-cancer-awareness-167x111.jpg",167,111,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/breast-cancer-awareness-280x187.jpg",280,187,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/breast-cancer-awareness-370x247.jpg",370,247,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/breast-cancer-awareness-960x640.jpg",960,640,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/breast-cancer-awareness.jpg",1280,853,false]},"uagb_author_info":{"display_name":"Dr. Christine Leduc, PharmD","author_link":"https:\/\/ameripharmaspecialty.com\/es\/author\/christine-leduc\/"},"uagb_comment_info":0,"uagb_excerpt":"Kisqali is an oral medication used to treat certain types of advanced or metastatic breast cancer. Kisqali is considered the first-line treatment option. It is also effective in extending survival when combined with hormone therapy.","rttpg_featured_image_url":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/breast-cancer-awareness.jpg",1280,853,false],"landscape":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/breast-cancer-awareness.jpg",1280,853,false],"portraits":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/breast-cancer-awareness.jpg",1280,853,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/breast-cancer-awareness-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/breast-cancer-awareness-300x200.jpg",300,200,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/breast-cancer-awareness-1024x682.jpg",1024,682,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/breast-cancer-awareness.jpg",1280,853,false],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/breast-cancer-awareness.jpg",1280,853,false],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/breast-cancer-awareness.jpg",18,12,false],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/breast-cancer-awareness.jpg",600,400,false],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/breast-cancer-awareness-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/breast-cancer-awareness-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/breast-cancer-awareness-86x57.jpg",86,57,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/breast-cancer-awareness-167x111.jpg",167,111,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/breast-cancer-awareness-280x187.jpg",280,187,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/breast-cancer-awareness-370x247.jpg",370,247,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/breast-cancer-awareness-960x640.jpg",960,640,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/breast-cancer-awareness.jpg",1280,853,false]},"rttpg_author":{"display_name":"Dr. Christine Leduc, PharmD","author_link":"https:\/\/ameripharmaspecialty.com\/es\/author\/christine-leduc\/"},"rttpg_comment":0,"rttpg_category":"<a href=\"https:\/\/ameripharmaspecialty.com\/es\/category\/cancer\/\" rel=\"category tag\">Cancer<\/a>","rttpg_excerpt":"Kisqali is an oral medication used to treat certain types of advanced or metastatic breast cancer. Kisqali is considered the first-line treatment option. It is also effective in extending survival when combined with hormone therapy.","_links":{"self":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts\/23493","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/comments?post=23493"}],"version-history":[{"count":0,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts\/23493\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/media\/23495"}],"wp:attachment":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/media?parent=23493"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/categories?post=23493"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/tags?post=23493"}],"curies":[{"name":"gracias","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}